J. Jervell

E. Bjertness, J. Jervell, H. Abdul-Rahim, 2000, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

Type 2 diabetes mellitus, impaired glucose tolerance and associated factors in a rural Palestinian village

E. Bjertness, R. Giacaman, J. Jervell, 2000, Diabetic medicine : a journal of the British Diabetic Association.

The utility of a single glucometer measurement of fasting capillary blood glucose in the prevalence determination of diabetes mellitus in an urban adult Palestinian population.

E. Bjertness, R. Giacaman, J. Jervell, 2000, Scandinavian journal of clinical and laboratory investigation.

Diabetes mellitus in an urban Palestinian population: prevalence and associated factors.

E. Bjertness, R. Giacaman, J. Jervell, 2001, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

Selected factors associated with diabetes mellitus in a rural Palestinian community.

E. Bjertness, R. Giacaman, J. Jervell, 2003, Medical science monitor : international medical journal of experimental and clinical research.

Type 2 Diabetes and Maternal Family History

K. Liestøl, G. Erikssen, J. Jervell, 2000 .

Simultaneous Pancreas and Kidney Transplantation: Indication and Results

P. Fauchald, H. Holdaas, J. Jervell, 1994 .

Insulin antagonistic effect of human plasma albumin on protein synthesis in vitro and on glycogen synthesis in vivo in the rat diaphragm muscle.

J. Jervell, 1966, Acta physiologica Scandinavica.

The Antagonistic Effect of Human Plasma Albumin on the Insulin Stimulated Glucose Uptake of the Isolated Rat Diaphragm

J. Jervell, 1965 .

INSULIN ACTIVITY OF NORMAL PLASMA AND PLASMA ACID-ETHANOL EXTRACTS

J. Jervell, 1964 .

Transcapillary colloid osmotic gradient, plasma volume and interstitial fluid volume in long-term Type 1 (insulin-dependent) diabetes

P. Fauchald, J. Jervell, J. Norseth, 1985, Diabetologia.

Sandostatin LAR®: Pharmacokinetics, pharmacodynamics, efficacy, and tolerability in acromegalic patients

I. Lancranjan, S. Lamberts, P. Kendall‐Taylor, 1995 .

Sandostatin LAR: a promising therapeutic tool in the management of acromegalic patients.

I. Lancranjan, H. Orskov, S. Lamberts, 1996, Metabolism: clinical and experimental.

Long-term metabolic control in recipients of combined pancreas and kidney transplants

A. Hartmann, P. Fauchald, H. Holdaas, 1991, Diabetologia.

BLOOD PRESSURE AND PULSE RESPONSE TO INSULIN‐INDUCED HYPOGLYCEMIA DURING NON‐SELECTIVE AND SELECTIVE β‐BLOCKADE

E. Thaulow, J. Jervell, H. Bergrem, 2009 .

A comparison of octreotide, bromocriptine, or a combination of both drugs in acromegaly.

J. Halse, O. Djøseland, J. Jervell, 1994, The Journal of clinical endocrinology and metabolism.

Insulin-dependent diabetes, medical progress, and late complications.

J. Jervell, 1988, The Journal of diabetic complications.

The metabolic syndrome in the West Bank population: an urban-rural comparison.

E. Bjertness, R. Giacaman, N. Gordon, 2001, Diabetes care.

Retraction of paper on maternal diabetes

R. T. Lie, G. Hawthorne, L. Irgens, 2003, BMJ : British Medical Journal.

Inhibition of glutathione reductase in diabetics and non-diabetics

J. Jervell, J. Vallance‐owen, 1967, Diabetologia.

Inhibition of Rat Liver Glutathione Reductase by the Reduced B-Chain of Insulin

J. Jervell, 1967 .

Novopen—A Useful Aid Also for Blind Diabetic Patients

J. Jervell, Eva Sommerfeldt, Rønnaug Øygard, 1989, Diabetes Care.

Metabolic profiles in closely controlled diabetic pregnancies during the third trimester

J. Jervell, J. Vidnes, H. Haugen, 1979, Diabetologia.

HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with Type 1 (insulin-dependent) diabetes and healthy subjects

E. Thorsby, Ø. Bruserud, J. Jervell, 1985, Diabetologia.

Diabetes mellitus and pregnancy — Management and results at Rikshospitalet, Oslo, 1970–1977

J. Jervell, N. Moe, J. Skjæraasen, 1979, Diabetologia.

Long-term treatment of macroprolactinomas with CV 205-502.

T. Bjøro, J. Halse, O. Djøseland, 1993, Acta endocrinologica.

A randomized study of SMS 201-995 versus bromocriptine treatment in acromegaly: clinical and biochemical effects.

A. Harris, O. Smiseth, O. Kjartansson, 1990, The Journal of clinical endocrinology and metabolism.

Importance of HLA-DR matching in cadaveric renal transplantation: a prospective one-center study of 170 transplants.

E. Thorsby, T. Moen, J. Jervell, 1980, The New England journal of medicine.

HLA-antigens in long standing insulin dependent diabetics with terminal nephropathy and retinopathy with and without loss of vision

J. Jervell, B. Solheim, 1979, Diabetologia.

A trial of a new adrenergic beta-receptor blocker, ICI 66.082, in the treatment of hypertension.

J. Erikssen, J. Jervell, 2009, Acta medica Scandinavica.

[The costs of hospital services].

J. Jervell, K. Forfang, 1982, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory

N. Abu-Rmeileh, A. Husseini, E. Bjertness, 2009, The Lancet.

Surgical correction of renovascular hypertension in patients with one kidney. A report of 9 cases.

J. Jervell, G. Sødal, A. Flatmark, 1980, Scandinavian journal of urology and nephrology.

Obesity in a rural and an urban Palestinian West Bank population

E. Bjertness, R. Giacaman, G. Holmboe-Ottesen, 2003, International Journal of Obesity.

Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy

F. Gries, A. Boulton, J. Jervell, 1998, Diabetic medicine : a journal of the British Diabetic Association.

Preliminary experience with extracorporeal renal surgery and autotransplantation.

I. Enge, J. Jervell, G. Sødal, 1977, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

SIGNIFICANCE OF HLA-D/DR MATCHING IN RENAL TRANSPLANTATION

E. Thorsby, J. Jervell, B. Solheim, 1978, The Lancet.

Influence of HLA matching in cadaveric renal transplantation: experience from one Scandiatransplant center.

E. Thorsby, T. Moen, J. Jervell, 2008, Tissue antigens.

HLA-DR ANTIGEN MATCHING IN CADAVER RENAL TRANSPLANTATION

E. Thorsby, J. Jervell, B. Solheim, 1978, The Lancet.

Influence of HLA-A, B, C, D, and DR matching in renal transplantation.

E. Thorsby, T. Moen, J. Jervell, 1981, Transplantation Proceedings.

The effect of blood transfusions on renal transplantation. Studies of 395 patients registered for transplantation with a first cadaveric kidney.

E. Thorsby, J. Pape, J. Jervell, 2008, Tissue antigens.

EFFECT OF BLOOD TRANSFUSIONS ON RENAL TRANSPLANTATION: STUDY OF 191 CONSECUTIVE FIRST TRANSPLANTS FROM LIVING RELATED DONORS

E. Thorsby, J. Pape, J. Jervell, 1980, Transplantation.

Influence of HLA-A, B, C, and D matching and pretransplant blood transfusions on kidney graft survival.

E. Thorsby, J. Jervell, A. Flatmark, 1979, Transplantation proceedings.

The influence of HLA-A, -B, -C, and -D matching on kidney graft survival.

E. Thorsby, E. Enger, J. Jervell, 1977, Scandinavian journal of urology and nephrology. Supplementum.

Influence of HLA-A, -B, -C, and -D matching on the outcome of clinical kidney transplantation.

E. Thorsby, E. Enger, J. Jervell, 1977, Transplantation proceedings.

Influence of blood transfusions on kidney transplant and uremic patient survival.

J. Jervell, B. Solheim, A. Flatmark, 1977, Scandinavian journal of urology and nephrology. Supplementum.

HLA-DR typing and B cell cross-match tests in cadaveric renal transplantation.

E. Thorsby, J. Jervell, B. Solheim, 1980, Scandinavian journal of urology and nephrology. Supplementum.

Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients.

J. Jervell, A. Flatmark, H. Bergrem, 1985, Kidney international.

Long-term results of treatment of Cushing's disease by adrenalectomy.

M. Hauer-Jensen, J. Jervell, A. Flatmark, 1991, The European journal of surgery = Acta chirurgica.

Goodpasture's syndrome. A report of seven patients including long-term follow-up of three who received a kidney transplant.

O. Mellbye, J. Jervell, A. Flatmark, 1980, The American journal of medicine.

Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.

J. Mustonen, S. Madsbad, B. Karlberg, 2004, The New England journal of medicine.

Sandostatin LAR in acromegalic patients: long-term treatment.

I. Lancranjan, J. Halse, S. Bakke, 1997, The Journal of clinical endocrinology and metabolism.

Sandostatin LAR in acromegalic patients: a dose-range study.

I. Lancranjan, T. Haldorsen, J. Halse, 1995, The Journal of clinical endocrinology and metabolism.

Sandostatin LAR in acromegalic patients

I. Lancranjan, T. Haldorsen, J. Halse, 1995 .

Cardiovascular effects of glucagon.

K. Rasmussen, J. Jervell, L. Westlie, 2009, Acta medica Scandinavica.

Digitoxin kinetics in patients with impaired renal function

L. Storstein, J. Jervell, K. Rasmussen, 1972, Clinical pharmacology and therapeutics.

[Pregnancy in diabetes].

J. Jervell, P. O. Dale, N. Moe, 1988, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Obesity and selected co-morbidities in an urban Palestinian population

Niveen M. E. Abu-Rmeileh, E. Bjertness, G. Holmboe-Ottesen, 2001, International Journal of Obesity.

Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria

L. Groop, P. Raskin, J. McGill, 1996 .

Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men.

S. Nitter‐Hauge, J. Erikssen, L. Sandvik, 1999, Diabetes care.

Different prednisolone pharmacokinetics in Cushingoid and non-Cushingoid kidney transplant patients.

J. Jervell, A. Flatmark, H. Bergrem, 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

A Desktop Guide for the Management of Non‐insulin‐dependent Diabetes Mellitus (NIDDM): An Update

F. Gries, K. Alberti, K G Alberti, 1994, Diabetic medicine : a journal of the British Diabetic Association.

Prognostic value of renal vein renin determination in suspected renovascular hypertension.

J. Jervell, A. Flatmark, H. Bergrem, 2009, Acta medica Scandinavica.

Response to bicycle exercise testing in long-standing juvenile diabetes.

L. Storstein, J. Jervell, 2009, Acta medica Scandinavica.

Care of vision and ocular health in diabetic members of a national diabetes organization: A cross-sectional study

P. Gulbrandsen, J. Straand, J. Jervell, 2008, BMC health services research.

Hypoglycemia and Insulin Pumps

K. Midthjell, M. Bjørgaas, J. Jervell, 1995, Diabetes Care.

Prediction of Type 2 diabetes in healthy middle‐aged men with special emphasis on glucose homeostasis. Results from 22.5 years' follow‐up

K. Liestøl, J. Erikssen, G. Erikssen, 2001, Diabetic medicine : a journal of the British Diabetic Association.

Arterial-hepatic vein glucose differences in normal and diabetic man after a glucose infusion at rest and after exercise.

S. Maehlum, J. Jervell, E. D. Pruett, 1976, Scandinavian Journal of Clinical and Laboratory Investigation.

Kaposi's sarcoma in a renal allograft recipient under longterm immunosuppressive therapy.

P. Wetteland, J. Jervell, L. Westlie, 1980, Scandinavian journal of urology and nephrology.

Severe or Life-Threatening Hypoglycemia in Insulin Pump Treatment

K. Midthjell, M. Bjørgaas, J. Jervell, 1994, Diabetes Care.

Renal Transplantation Combined with Pancreas Transplantation: Is There a Clinical Indication?

P. Fauchald, J. Jervell, I. Brekke, 1988 .

[Where does the Norwegian international health contribution go?].

B. Claussen, A. Hussain, G. Holmboe-Ottesen, 2009, Tidsskrift for Den Norske Laegeforening.

In-vivo effects of the synalbumin insulin antagonist and of B-chain albumin.

J. Jervell, J. Vallance‐owen, 1967, Lancet.

Variations in synalbumin insulin antagonism during glucose-tolerance tests.

J. Jervell, J. Vallance‐owen, 1967, Lancet.

Clinical use of a bio-assay of serum digitoxin activity

K. Rasmussen, J. Jervell, O. Storstein, 1971, European Journal of Clinical Pharmacology.

[Treatment of diabetes and quality of life. On possibilities of a more normalized life style using an insulin pen for multi-injection therapy].

I. Andresen, J. Jervell, P. Paus, 1989, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.